Radioimmunoassay for human calcitonin (hCT) was established by many investigators several years ago (Clark et al., 1969 , Tashjian et al., 1970 Deftos, 1971; Silna et al., 1974; Dietrich et al., 1975) and its clinical application has widely introduced the presence of hypercalcitonemia in patients with medullary carcinoma and provocative tests for hCT secretion (Deftos et al., 1971; Sizemore et al., 1973; Heyman and Franchimont, 1974; Rud and Singer, 1977) However, the application of synthetic hCT analogue to radioimmunoassay has not been reported. This paper describes radioimmunoassay for hCT using [Asu1, 7]-hCT analogue (hCT analogue), which has been confirmed to be chemicaly more stable than native hCT (Sakakibara, 1978) . normal rabbit serum were added and in 24 hr the reaction mixtures were centrifused at 3,000 rpm for 30 min. Dilution of all the materials used for assay was performed with the diluent. The inhibition dose 50 (ID50), defined as the amount of inhibitor required to reduce specific binding to 50% was determined graphically. Synthetic eel calcitonin analogue, [ Asul, 7] -eCT (eCT analogue) was kindly supplied by Toyo Jojo Co., Ltd. Synthetic hCT fragments (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) 336, 337) were used for evaluating specificity of the antibodies produced. showed two peaks, namely the one labeled hCT and the other salt. Further purification of the first fraction on Sephadex G-50 revealed one peak as shown in Fig. 1 . 131I was applied to the same column , but no peak of 1251 was detected in the fraction of 131I peak. Peak fraction of 125I-hCT analogue was used for assay.
Materials and Methods
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Titration
and quality of antibodies to hCT analogue and to hCT At the 4th month of immunization of hCT analogue to 3 rabbits, serum samples were checked for the presence of antibodies binding to 125I-hCT analogue.
The initial dilutions of antibodies to yield approximately 30 % of bound labeled hCT analogue were 1: 2500 and 1: 3000 in the two sera, but no antibodies were detected in the rest of the sera.
Specificities of antibodies to hCT analogue were studied of labeled hCT analogue on Sephadex G 50 after Sephadex G 15. 131I was added to 125I-hCT analogue before gel filtration and each fraction was simultaneously counted for radioactivity of 131I and 125I. No significant peak of 125I (salt) was detected in the peak fraction of 131I added . Vol.25, No.6 RIA OF HUMAN CALCITONIN by measuring the inhibition dose requiring to reduce binding to 50%. Fig. 2 shows the inhibition of binding by hCT analogue, hCT, fragments (11-32, 17-32, 21-32) and eCT, when labeled hCT analogue was used as a tracer.
However, when labeled hCT was used as tracer, inhibition of binding by hCT and hCT analogue was similar to that of fragments, though'bound'per- centage at 0 point (BIT) was only 10.2%. At the 12th week of immunization of hCT, sera obtained from 5 rabbits were also checked for the binding of labeled hCT analogue.
Serial dilutional experiments disclosed that antibodies could be used at the titer 1 : 10000 to 34000 in all 5 sera. Fig. 3 shows inhibition patterns of binding by hCT, hCT analgoue, hCT fragments and Antibodies to hCT and hCT analogue and commercially available antibodies to hCT (Calbiochem) were studied for their specificity. Antibodies to hCT analogue (Lot No. 62-0322) are likely to be specific to N terminus and antibodies to hCT (Lot. No. 82-1208) had specificity to the middle part of aminosequence, while antibodies (Calbilchem) to C terminus.
eCT when the antibodies to hCT are applied to the assay system. The inhibition doses of hCT, hCT analogue, hCT fragments and eCT are summarized in Table 1 
Discussion
One of the biggest problems to establish radioimmunoassay of any peptide hormone is the stability of tracer used. Biological activity of hCT analogue used was 200 MRC unit, and this was confirmed to be chemically far more stable than native hCT (Sakakibara, 1977) . This was the same with labeled hCT analogue in our study, since the damaged material of labeled hCT analogue was negligible when this tracer Optimal pH of incubation mixture seems to be between 6.4 and 7.4 when the double antibody technique is applied. Recovery, sensitivity, and reproducibility were satisfactory for routine radioimmunoassay.
Furthermore, high concentration of serum hCT was demonstrated in patients with medullary carcinoma and the dilution curves well paralelled with the standard curve. These results indicate that this assay system using labeled [Asu1,7]-hCT analogue can be utilized as routine radioimmunoassay for human calcitonin.
Further investigations are scheduled in order to study if hCT concentrations in sera obtained from patients with chronic renal failure or patients with medullary carcinoma differ when different antibodies are used
